RBR-986tpd招募中未知
Metabolomic analysis in Polycystic Ovarian Syndrome and its application in a randomized clinical trial with calcium and vitamin D supplementation.
niversidade Federal de Minas Gerais - UFMG0 个研究点开始时间: 2019年9月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 40Y（—）
- 性别
- Female
入选标准
- •Clinical trial: women with medical diagnosis of Polycystic Ovarian Syndrome; age between 18 and 40 years.
排除标准
- •Type II diabetes; autoimmune disease; adrenal, renal and hepatic diseases; thyroid disorders; cancer or tumors; acute inflammatory disease; hyperprolactinemia; hypogonadism and pregnancy. Volunteers treated with the following medications will also be excluded: steroid and non-steroidal anti-inflammatories; isotretinoin; cyclosporin; antiretrovirals; insulin; metformin and oral contraceptives.
研究者
相似试验
Unknown
不适用
Serum Metabolomics Study of Polycystic Ovary SyndromePolycystic Ovary SyndromeNCT03618342Heilongjiang University of Chinese Medicine1,272
已完成
4 期
Metformin and Lifestyle Intervention in Women With Polycystic Ovary SyndromePolycystic Ovary SyndromeNCT00679679Hospital Privado de Cordoba, Argentina30
招募中
不适用
Characterization of a Prospective Cohort of Women With PCOSPolycystic Ovary SyndromeNCT02010814Odense University Hospital500
Unknown
不适用
Women With Polycystic Ovary Syndrome (PCOS)Polycystic Ovary SyndromeNCT02467751Irmandade da Santa Casa de Misericordia de Sao Paulo90
已完成
4 期
Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin ResistancePCOSPolycystic Ovary SyndromeNCT01511822AGUNCO Obstetrics and Gynecology Centre